J&J's increased passive stake adds to a cluster of recent institutional 13G filings (Fidelity, Squadron Capital, Franklin Templeton) over the past two weeks. Monitor for any conversion to a 13D or further accumulation, though the passive certification suggests no imminent activist intent.
CTNM drugs
CTNM drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $9.52entry
- T+1 · 8d ago +8.19%α +5.83% · $10.30
- T+5 · 4d ago +3.57%α +0.98% · $9.86
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Johnson & Johnson Innovation-JJDC (a J&J subsidiary) filed an amended Schedule 13G disclosing a 5.6% passive stake in Contineum Therapeutics as of November 3, 2026, up from a prior filing. The stake consists of 1,979,173 shares, and the filing reaffirms passive intent with no control influence.
Key Financial Metrics
Key Facts
- Johnson & Johnson Innovation-JJDC disclosed 1,979,173 shares of CTNM common stock, representing 5.6% of shares outstanding.
- The filing is an amendment to a prior Schedule 13G, indicating an increase from the previously reported stake.
- The stake is based on 35,353,313 shares outstanding as of October 30, 2026.
- The filing certifies passive intent under Rule 13d-1(c), with no purpose of changing or influencing control.
Financial Impact
Stake valued at approximately $21.8M based on market cap of $384M and 5.6% ownership.
Risk Factors
- No material risks identified; routine passive stake amendment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000904454-26-000591 |
| Document: 0000904454-26-000591-index.html | 0000904454-26-000591 |
| Document: 0000904454-26-000591.txt | 0000904454-26-000591 |
Track record
14 reports on CTNM
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $9.72 Now $9.67 −0.46% settles Dec 15
- Nov 10, 20266d ago Institutional Cluster Neutral 2/10 Entry $10.56 Now $9.67 −8.43% settles Dec 9
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Viewing Entry $9.52 Now $9.67 +1.58% settles Dec 7
- Nov 5, 202611d ago SC 13G Neutral 4/10 Entry $8.81 Now $9.67 +9.76% settles Dec 4
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $8.81 Now $9.67 +9.76% settles Dec 4
- Nov 3, 202613d ago 8-K Neutral 3/10 Entry $9.79 Now $9.67 −1.23% settles Dec 3
- Oct 28, 202619d ago SC 13G Neutral 3/10 Entry $9.33 Now $9.67 +3.64% settles Nov 27
- Oct 28, 202619d ago SC 13G/A Neutral 2/10 Entry $9.15 Now $9.67 +5.68% settles Nov 25
- Oct 22, 202625d ago SC 13G Neutral 3/10 Entry $8.31 Now $9.67 +16.37% settles Nov 20
- Sep 22, 20267w ago Institutional Cluster Mixed 3/10 Entry $13.40 to $8.46 Now $9.67 −27.84% ▼ −36.87% −36.31% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers